ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, offering promising improvements across several clinical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, extra reputable substitute for therapeutic use, speci